Open AccessDual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease
Author(s) -
Susmeeta T. Sharma
Publication year - 2020
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgaa845
Subject(s) - cushing's disease , pi3k/akt/mtor pathway , medicine , disease , dual (grammatical number) , pharmacology , cancer research , chemistry , biochemistry , philosophy , signal transduction , linguistics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom